Phase 2 Trials of BCMA Targeted Therapy - Find safety, toxicity, and efficacy in a larger patient population

Phase 2 Trials of BCMA Targeted Therapy - Find safety, toxicity, and efficacy in a larger patient population

User Photo
ASHReport

3 years
211 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Sagar Lonial, MD from Winship Cancer Institute of Emory University discusses phase 2 trials of BCMA targeted therapy and finding safety, toxicity, and efficacy in a larger patient population at the 2017 American Society of Hematology.
Up Next Autoplay
>